Publications by authors named "Pascale Exer"

Claim this Profile
E
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.
Adrian Ciurea, Andrea Götschi, René Bräm, Kristina Bürki, Pascale Exer

RMD Open· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry.
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, Burkhard Möller, Axel Finckh, Pascale Exer

Clin Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years.
Caroline Ensslin, Raphael Micheroli, Seraphina Kissling, Andrea Götschi, Kristina Bürki, Pascale Exer

RMD Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry.
Adrian Ciurea, Andrea Götschi, Seraphina Kissling, Alexander Bernatschek, Kristina Bürki, Pascale Exer

RMD Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry.
Fabienne Fröhlich, Raphael Micheroli, Monika Hebeisen, Seraphina Kissling, Kristina Bürki, Pascale Exer

Clin Rheumatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry.
Vjara Popova, Seraphina Kissling, Raphael Micheroli, René Bräm, Manouk de Hooge, Pascale Exer

Arthritis Res Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry.
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, Pascale Exer, René Bräm

RMD Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort.
Adrian Ciurea, Seraphina Kissling, Kristina Bürki, Xenofon Baraliakos, Manouk de Hooge, Pascale Exer

RMD Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort.
Regula Neuenschwander, Monika Hebeisen, Raphael Micheroli, Kristina Bürki, Pascale Exer

Arthritis Res Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort.
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, Kristina Bürki, Karin Niederman, Pascale Exer

Ann Rheum Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.
Monika Hebeisen, Raphael Micheroli, Almut Scherer, Xenofon Baraliakos, Manouk de Hooge, Pascale Exer

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
Monika Hebeisen, Almut Scherer, Raphael Micheroli, Michael J Nissen, Giorgio Tamborrini, Pascale Exer

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.
Monika Hebeisen, Regula Neuenschwander, Almut Scherer, Pascale Exer, Ulrich Weber

J Rheumatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
Christoph Molnar, Almut Scherer, Xenofon Baraliakos, Manouk de Hooge, Raphael Micheroli, Pascale Exer

Ann Rheum Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
Raphael Micheroli, Monika Hebeisen, Lukas M Wildi, Pascale Exer, Giorgio Tamborrini

Arthritis Res Ther· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis.
Michael J Nissen, Adrian Ciurea, Jürg Bernhard, Giorgio Tamborrini, Ruediger Mueller, Pascale Exer

Arthritis Rheumatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.
Adrian Ciurea, Pascale Exer, Ulrich Weber, Giorgio Tamborrini, Beate Steininger

Arthritis Res Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.
Adrian Ciurea, Almut Scherer, Ulrich Weber, Pascale Exer, Jürg Bernhard

Ann Rheum Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
Adrian Ciurea, Ulrich Weber, Daniel Stekhoven, Almut Scherer, Giorgio Tamborrini, Pascale Exer

J Rheumatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age at symptom onset in ankylosing spondylitis: is there a gender difference?
Adrian Ciurea, Almut Scherer, Ulrich Weber, Regula Neuenschwander, Giorgio Tamborrini, Pascale Exer

Ann Rheum Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Adrian Ciurea, Almut Scherer, Pascale Exer, Jürg Bernhard, Jean Dudler

Arthritis Rheum· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis